Lactate Biomarker May Predict Outcomes in Cardiogenic Shock - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Lactate Biomarker May Predict Outcomes in Cardiogenic Shock

A review of cardiogenic shock studies suggests serial lactate measurements provide more prognostic information than isolated values and may better reflect treatment response.

  • By

  • Andrea Surnit

  • June 23, 2026

  • 4 min

Share

Objective:

To synthesize evidence on the pathophysiology, prognostic value, and clinical interpretation of serum lactate in patients with cardiogenic shock.

Approach:
  • Evidence Review: Investigators reviewed clinical trials, registries, observational studies, and studies involving temporary mechanical circulatory support.
Key Findings:
  • Admission lactate is associated with shock severity and mortality.
  • Lactate thresholds of approximately 3 to 3.5 mmol/L indicate higher risk of short-term mortality.
  • A baseline lactate level of 5 mmol/L predicts 30-day mortality in acute myocardial infarction-related cardiogenic shock.
  • Serial lactate monitoring reflects metabolic recovery and response to therapy.
  • Lactate measured 8 hours after presentation predicts 30-day mortality more accurately than baseline lactate.
  • Reductions in lactate during the first 12 to 24 hours are associated with improved survival.
  • Complete lactate clearance is a strong predictor of survival.
  • Persistent hyperlactatemia despite adequate device flow indicates poor outcomes.
Interpretation:

Lactate levels reflect disease severity and should be interpreted in the context of clinical conditions, not as standalone measures.

Limitations:
  • The review is a narrative synthesis of heterogeneous sources.
  • Lactate values should be interpreted within the broader clinical context.
Conclusion:

Trajectory-based lactate assessment may provide important information for risk stratification and therapeutic guidance.

Sources:

Original Source(s)

Lactate Biomarker May Predict Outcomes in Cardiogenic Shock

  • by Andrea Surnit

  • June 23, 2026

Related Content

Guanxinjing ameliorates coronary microvascular dysfunction in myocardial ischemia-reperfusion injury by alleviating inflammation and restoring endothelial function

AHA: Coffee Need Not Be Avoided in AF

Moderate coffee consumption generally appeared safe for most adults, but randomized evidence suggested divergent effects on atrial fibrillation and premature ventricular contractions.

Serostatus May Modify RA Activity–CV Link

Combined rheumatoid factor and anticitrullinated protein antibody status appeared to modify the association between baseline rheumatoid arthritis disease activity and subsequent cardiovascular events in an international observational cohort.